American Heart Association--scientific sessions 2005. Potential new drugs for various indications. 13-16 November 2005, Dallas, TX, USA.
Finn
Paula
P
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. paula.finn@thomson.com
D000572:American Heart Association; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D047494:PPAR delta / Q000819:agonists; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D026902:Potassium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use; D000077285:Rimonabant; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use
D002316:Cardiotonic Agents; C503394:GW 610742; D047494:PPAR delta; D010880:Piperidines; D026902:Potassium Channel Blockers; D011720:Pyrazoles; D013844:Thiazoles; D000077285:Rimonabant